| 标题 |
Atezolizumab plus platinum-pemetrexed versus platinum-pemetrexed alone for first-line metastatic non-squamous NSCLC (IMpower132): a randomised, open-label, phase 3 trial[J] |
| 网址 | |
| DOI |
10.1016/S1470-2045(21)00070-0
doi
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)